medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2016, Number 4

<< Back Next >>

Arch Med Fam 2016; 18 (4)

Validation of the Questionnaire: 'Quality of life of Patients with Allergic Rhinitis'

Rivera-Ávila DA, Ponce-Rosas ER, Avilés-Román A, Jiménez-Galván I

Language: Spanish
References: 22
Page: 85-93
PDF size: 291.73 Kb.


ABSTRACT

Objective: To validate the Mexican Spanish version of the modified Rhinoconjunctivitis Quality of Life Questionnaire (mRQLQ). Material and methods: Observational, prospective, and cross sectional study. Setting: This study was conducted at an ISSSTE institutional referral center in Mexico City. Participants: Patients with Rhinoconjuntivitis, between 6 and 80 years, both genders. Non-probabilistic quota sampling, 52 patients first visiting between October 2013 and October 2014. Instrument. The 29 items that explored seven dimensions (nasal symptoms, eye symptoms, physical health, practical problems, social function, emotional function, sleep, and productivity was designed to be applied and with outcome of the English versions of the RQLQ and the WPAIS, and the Beck Depression Inventory was translated, culturally adapted, and tested. The response to each item was measured on an ordinal Likert scale. The ARIA questionnaire was also used to compare the classification. Results: Mean age was 37.6 ± 18.76 years, women 68%. Reliability: Cronbach’s alpha coefficient α = 0.98, and factor analysis: KMO = 0.644 (satisfactory sampling adequacy). Bartlett sphericity test p ‹0.001, (proper identity matrix). Factors obtained: seven (confirmatory). Explained variance: 74.72%; range of high factor loadings (0.494–0.913). Conclusions: The mRQLQ proved to be a reliable and valid instrument in patients with seasonal or perennial Allergic Rhinitis (AR); model validation largely exceeded the minimal assumptions of their construct. Limitations: It is necessary to continue the modified RQLQ in other populations, in different scenarios to have more elements that contribute to assessing their validity.


REFERENCES

  1. Dullaers M, De Bruyne R, Ramadani F, Gould HJ, Gevaert P, Lambrecht BN. The who, where, and when of IgE in allergic airway disease. The Journal of allergy and clinical immunology [Internet]. Elsevier Ltd; 2012 Mar [cited 2013 Sep 23]; 129(3):635–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22168998

  2. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Review article Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization. GA(2)LEN an AllerGen). Allergy 2008;63:8–160.

  3. Halpern, L. R. Allergic rhinitis and the unified airway: a therapeutic dilemma. Oral and Maxillofacial Surgery Clinics of North America 2012 [cited 2013 May 9]; 24(2), 205–17, viii. http://doi.org/10.1016/j.coms.2012.01.012.

  4. Small P, Kim H. Allergic Rhinitis Review. Allergy, Asthma Clin. Immunol. [Internet]. 2011; [cited 2013 Sep 23]; 7(S1):1–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12653792

  5. Mims JW. Allergic rhinitis. Facial Plast Surg Clin North Am [Internet]. Elsevier Inc; 2012 Feb [cited 2013 Sep 23];20(1):11–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22099613

  6. Hellings PW, Fokkens WJ, Akdis C, Bachert C, Cingi C, Dietz de Loos D, et al. Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy [Internet]. 2013 Jan [cited 2013 Sep 23];68(1):1–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23025484

  7. Pérez GL, María B, Maciel M, López JH, Mejía F, López JL, et al. Artículo original Prevalencia de las enfermedades alérgicas en la Ciudad de México. 2009;56(3):72–9

  8. Meltzer E, Gross GN, Katial R, Storms W. Allergic rhinitis substantially impact patient quality of life: Finding From the nasal allergy surgery assessing limitations. Family practice 2012, 61(12): 5-10 [Cited 2013 Jun 22]. Available from: http://www.jfponline.com/Pages.asp?AID=10244

  9. Bousquet J, Bullingger M, Fayol C, Marquia P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial rhinitis with the French version of the SF-36 health status questionnaire. J Alelergy Clin Immunol 1994; 94.182-88

  10. WHOQOL GROUP The World Health Organization Quality of life assessment (WHOQOL). Position Paper from the World Health Organization. Soc. Sci. Med 1995; 41, (10): 1.403-1.409.

  11. Schipper H, Clinch J, Powell V. Definitions and conceptual issues. In: Spilker B, ed. Quality of life assessment in clinical trials. New York: Raven Press, 1990:11-24.

  12. Van Oene CM, van Reij EJF, Sprangers MAG, Fokkens WJ: Quality-assessment of disease-specific quality of life questionnaires for rhinitis and rhinosinusitis: a systematic review. Allergy European Journal of Allergy and Clinical Immunology. 2007; [cited 2013 Jul 4]; 62(12):1359–1371. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17983371)

  13. Demoly P, Calderon M a, Casale T, Scadding G, Annesi-Maesano I, Braun J-J, et al. Assessment of disease control in allergic rhinitis. Clinical and translational allergy [Internet]. 2013 Feb 18 [cited 2013 Mar 4]; 3(1):7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23419058

  14. Bousquet PJ, Bachert C, Canonica GW, Casale TB, Mullol J, Klossek JM et al. Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial. J Allergy Clin Immunol 2010;126:666–668 e661–665

  15. Brozek JL, Bousquet J, Baena- Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ: allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update. Global Allergy and Asthma European Network, Grading of Recommendations Assessment, Development and Evaluation Working Group, Allergy 2008, 63: S8-160.

  16. De la Hoz Caballer B, Rodríguez M, Fraj J, Cerecedo I, Antolín-Amérigo D, Colás C. Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: the Cross-sectional study to evaluate work Productivity in allergic Rhinitis compared with other common diseases (CAPRI) study. Am. J. Rhinol. Allergy [Internet]. 2012 [cited 2014 Feb 1];26(5):390–4. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3904041&tool=pmcentrez&rendertype=abstract

  17. de Graaf-in’t Veld T, Koenders S, Garrelds IM, Gerth van Wijk R. The relationship between nasal hyperreactivity, quality of life and nasal symptoms in perennial, allergic rhinitis. J Allergy Clin Immunol 1996; 98: 508-13.

  18. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999;1: 364–369.

  19. Reillyassociates.net [Internet]; 2002 WPAI+CIQ: AS (Allergy-Specific Work Productivity and Activity Impairment questionnaire WPAI+CIQ:SHP, Version 2.0 [cited 2013 May 23] http://www.reillyassociates.net/WPAI_Translations.html#anchor_201

  20. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory–II. San Antonio, TX: Psychological Corporation; 1996.

  21. Valero A, Muñoz-Cano R, Sastre J, Navarro AM, Martí-Guadaño E, Dávila I, del Cuvillo A, Colás C, Antépara I, Izquierdo I, Mullol J. The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of ARIA severity classification. Rhinology. 2012 Mar; 50(1) 33-36. doi:10.4193/rhino11.071. PMID: 22469603.

  22. Soler, R., Badia, X., Mercadal, J., Lozano, R., & Benavides, Validación de la versión española del cuestionario de calidad de vida para pacientes con rinoconjuntivitis. Rev Clin Esp 2015; 204(3), 131–138.




2020     |     www.medigraphic.com